Recent Oncology/Hematology Research for November 2024
Lung Cancer Therapeutics
Topics: Research & Development, Prescription Drugs, Drug Discovery, Respiratory/Pulmonary, Oncology/Hematology
Regions: Global
| Hematology Testing Products
Topics: Hematology & Oncology, Oncology/Hematology
| Europe Ovarian Cancer Market - 2023-2030
Topics: Cancer Treatment, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Europe
| Global Fiducial Markers Market - 2023-2030
Topics: Cancer Treatment, Implantable Devices, Oncology/Hematology
Regions: Global
| 2023 Netherlands Molecular Diagnostics Market: 2022 Supplier Shares, Instrumentation Installed Base and Strategies, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
Topics: Instrumentation & Equipment, Cancer Treatment, Molecular Diagnostics, Oncology/Hematology
Regions: Netherlands
| Saudi Arabia Nuclear Imaging Equipment Market, By Type (PET Imaging Systems, Gamma Camera Imaging Systems), By Application (Oncology, Cardiology, Neurology, Others), By End User (Hospitals & Clinics, Diagnostic Imaging Centers, Others), By Region, Competi
Topics: Nuclear Medicine, Cardiovascular, CNS/Neurology, Oncology/Hematology
Regions: Saudi Arabia
| 2023 Ireland Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Ireland
| Acute Myeloid Leukemia (AML) - Drug Pipeline Landscape, 2023
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals, Specialty Clinics, Diagnostic Labs, Research and Academic Institutes) & Region - Global Forecast to 2027
Topics: Molecular Biology, Cancer Treatment, Hospitals & Clinics, Histology & Cytology, Oncology/Hematology
Regions: Global
| Breast Cancer Liquid Biopsy
Topics: Molecular Biology, Biomarkers, Cancer Treatment, Minimally Invasive Surgery, Women's Health, Oncology/Hematology
| Cancer Immunotherapy
Topics: Research & Development, Cancer Treatment, Research & Development, Drug Discovery, Oncology/Hematology
| Cancer Registry Software
Topics: Cancer Treatment, Oncology/Hematology
| Cancer Stem Cells
Topics: Stem Cell, Cancer Treatment, Oncology/Hematology
Regions: Global
| Cervical Cancer Treatment
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Next Generation Cancer Diagnostics
Topics: Next Generation Sequencing, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
| U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030
Topics: Biomarkers, Cancer Treatment, Oncology/Hematology, Men's Health
Regions: United States
| Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladd
Topics: Molecular Biology, Biomarkers, Cancer Treatment, COVID-19/Coronavirus, Hospitals & Clinics, Hematology & Oncology, Minimally Invasive Surgery, Computed Tomography (CT), Mammography, NMR & MRI, Ultrasonography, Radiology, Oncology/Hematology, Men's Health
Regions: Global
| 2023 Middle East Cancer Diagnostics Market in 11 Countries-2022 Supplier Shares and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Middle East
| 2023 Mexico Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Mexico
| Oncology Information Systems
Topics: Cancer Treatment, EMR (Electronic Medical Record), Internet of Things IoT, Oncology/Hematology
Regions: Global
| Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2023-2029
Topics: Stem Cell, Cancer Treatment, Oncology/Hematology
Regions: Global
| Precision Medicine Software Forecasts to 2028 – Global Analysis By Delivery Mode (Web & Cloud Based, On Premise), Application (Pharmacogenomics, Oncology, Rare Diseases, Other Applications), End User (Research & Government Institutes, Healthcare Providers
Topics: Genomics, Personalized Medicine, Cloud Computing, Oncology/Hematology
Regions: Global
| Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032
Topics: Genomics, Microarray , Cancer Treatment, Oncology/Hematology
| 2023 China Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: China
| 2023 El Salvador Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: El Salvador
| 2023 Estonia Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Estonia
| 2023 Egypt Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Egypt
| 2023 Europe Cancer Diagnostics Market in France, Germany, Italy, Spain, UK-2022 Supplier Shares and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: France, Germany, Italy, Spain, United Kingdom
| Uterine Cancer Therapeutics and Diagnostics
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| 2023 France Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: France
| Genomics in Cancer Care
Topics: Genomics, Research & Development, Cancer Treatment, Oncology/Hematology
| Head and Neck Cancer Therapeutics
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| NDDS in Cancer Therapy
Topics: Nanomedicine, Cancer Treatment, Oncology/Hematology
| Leuprolide Acetate Market Size, By Application (Cancer [Prostate Cancer, Breast Cancer, Cervix Uteri, Ovary Cancer, Testis], Radical Prostatectomy, Central Precocious Puberty, Endometriosis, Hormone Therapy, Uterine Fibroids), By Product Form (Lyophilized
Topics: Cancer Treatment, Hospitals & Clinics, Surgical Equipment, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores, Oncology/Hematology, Men's Health, Obstetrics/Gynecology
| Chronic Myelogenous Leukemia Treatment
Topics: Cancer Treatment, Prescription Drugs, Drug Discovery, Oncology/Hematology
| 2023 Haiti Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Haiti
| 2023 India Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: India
| 2023 Jordan Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Jordan
| Pet Cancer Therapeutics Market Size, By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy), By Route of Administration (Oral, Injection), By Species (Dogs, Cats), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary, and
Topics: Cancer Treatment, Pet Care Services, Prescription Drugs, Drug Discovery, Oncology/Hematology
| 2023 Belarus Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Belarus
| Immunotherapy Drugs
Topics: Autoimmune, Research & Development, Oncology/Hematology
Regions: Global
| Leukemia Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
Topics: Cancer Treatment, COVID-19/Coronavirus, Drug Discovery, Oncology/Hematology
| Genomics in Cancer Care Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
Topics: Genomics, Cancer Treatment, COVID-19/Coronavirus, Oncology/Hematology
| 2023 Kenya Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Kenya
| 2023 France Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies a
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: France
| 2023 Kenya Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies an
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Kenya
| 2023 France Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strat
Topics: Instrumentation & Equipment, Hospitals & Clinics, Hematology & Oncology, Histology & Cytology, Point-of-Care, Oncology/Hematology
Regions: France
| 2023 Germany Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Stra
Topics: Instrumentation & Equipment, Hospitals & Clinics, Hematology & Oncology, Histology & Cytology, Point-of-Care, Oncology/Hematology
Regions: Germany
| Biological Therapies for Cancer
Topics: Antibody Technologies, Cancer Treatment, Oncology/Hematology
Regions: Global
| 2023 Mexico Hematology and Flow Cytometry Analyzers and Reagents Market - 2022 Supplier Shares, 2022-2027 Test Volume and Sales Segment Forecasts for over 40 Individual Tests, Growth Opportunities - Competitive Strategies, Instrumentation Pipeline, Emergi
Topics: Instrumentation & Equipment, Hematology & Oncology, Histology & Cytology, Oncology/Hematology
Regions: Mexico
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
